Vadim Sapiro - OpGen Chief Officer

OPGNDelisted Stock  USD 1.90  0.15  7.32%   

Executive

Mr. Vadim Sapiro serves as Chief Information Officer of the Company. He joined the Company in December, 2011 as Chief Information Officer. Mr. Sapiro is responsible for leading the development of the Company bioinformatics applications, software, databases and information technology operations. Prior to OpGen, Mr. Sapiro was senior vice president at SAICFrederick, or SAIC, from June 2008 to December 2011, overseeing the Information Systems Program for the National Cancer Institute at Frederick with responsibility for information technology, scientific computing and bioinformatics. Among Mr. Sapiro projects were technical program management and operations for the cancer Biomedical Informatics Grid, the cancer Human Biobank and The Cancer Genome Atlas . Prior to SAIC, from July 1999 to May 2008, Mr. Sapiro was Vice President for Information Technology with the J. Craig Venter Institute. Mr. Sapiro is active in the regional and national technology and research communities, having served on many life sciences and biotech focused advisory boards and review committees since 2011.
Age 53
Tenure 14 years
Phone240 813 1260
Webhttps://www.opgen.com
Sapiro holds a B.S. in Mathematics and Computer Science from the University of Maryland.

OpGen Management Efficiency

The company has return on total asset (ROA) of (0.5224) % which means that it has lost $0.5224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.1492) %, meaning that it created substantial loss on money invested by shareholders. OpGen's management efficiency ratios could be used to measure how well OpGen manages its routine affairs as well as how well it operates its assets and liabilities.
OpGen Inc currently holds 13.04 M in liabilities with Debt to Equity (D/E) ratio of 1.11, which is about average as compared to similar companies. OpGen Inc has a current ratio of 1.1, suggesting that it may not be capable to disburse its financial obligations when due. Debt can assist OpGen until it has trouble settling it off, either with new capital or with free cash flow. So, OpGen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like OpGen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for OpGen to invest in growth at high rates of return. When we think about OpGen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

EXECUTIVE Age

Dylan JohnNeuropace
N/A
Lisa WolfTivic Health Systems
62
Vitaliy EpshteynNuwellis
46
Susan RNNeuroMetrix
N/A
Meshira GreenbergInspira Technologies Oxy
N/A
Yafit TehilaInspira Technologies Oxy
42
Michael SouleMovano Inc
N/A
Andrew CormackenVVeno Medical Corp
N/A
Shmuel GovSTRATA Skin Sciences
65
Thomas StankovichReShape Lifesciences
64
Adi NirInspira Technologies Oxy
N/A
Stephen JDSight Sciences
N/A
Ruth HembreeVivos Therapeutics
N/A
Brenton TaylorSight Sciences
44
Eryn GrahamBluejay Diagnostics
N/A
Indranil DeyBluejay Diagnostics
62
Sandy PriettoenVVeno Medical Corp
N/A
Amy TreadwellNeuropace
N/A
Irene ThomasNeuropace
55
Matthew LinkSight Sciences
Amir RippelNanoVibronix
N/A
OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. The company was incorporated in 2001 and is headquartered in Rockville, Maryland. Opgen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 91 people. OpGen Inc [OPGN] is a Pink Sheet which is traded between brokers as part of OTC trading. OpGen is listed under Healthcare category by Fama And French industry classification.

Management Performance

OpGen Inc Leadership Team

Elected by the shareholders, the OpGen's board of directors comprises two types of representatives: OpGen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OpGen. The board's role is to monitor OpGen's management team and ensure that shareholders' interests are well served. OpGen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OpGen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Albert Weber, CFO Secretary
Michael Farmer, VP Marketing
Honjian Tan, CEO Chairman
Arne Materna, MD GmbH
Terrance Walker, Sr. VP of RandD
Derek Joesting, VP Sales
Vadim Sapiro, Chief Officer
Faranak Atrzadeh, Chief Officer
Theo deVos, MD Genetics
David Lazar, CEO Chairman
Johannes Bacher, Chief Officer
Oliver Schacht, Executive Development

OpGen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is OpGen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with OpGen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OpGen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OpGen will appreciate offsetting losses from the drop in the long position's value.

Moving against OpGen Pink Sheet

  0.6BDMD Baird Medical Investment Upward RallyPairCorr
  0.44BSGM BioSig Technologies,PairCorr
  0.42VASO Vaso CorpPairCorr
  0.38NMRD Nemaura MedicalPairCorr
  0.32ADMT Adm Tronics UnltdPairCorr
The ability to find closely correlated positions to OpGen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OpGen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OpGen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OpGen Inc to buy it.
The correlation of OpGen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OpGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OpGen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OpGen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Consideration for investing in OpGen Pink Sheet

If you are still planning to invest in OpGen Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OpGen's history and understand the potential risks before investing.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments